Travaux scientifiques

Prof. Dr. Yaşar Çolak

74 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores.

    PubMed, 2012

    PMID 23042372 29 citations (Europe PMC) Source : OpenAlex

  2. Nonalcoholic Fatty Liver Disease: A Nutritional Approach

    Metabolic Syndrome and Related Disorders, 2012

    DOI 10.1089/met.2011.0145 PMID 22394108 19 citations (Europe PMC) Source : OpenAlex

  3. Concentrations of Connective Tissue Growth Factor in Patients with Nonalcoholic Fatty Liver Disease: Association with Liver Fibrosis

    Disease Markers, 2012

    DOI 10.1155/2012/283726 PMID 22846210 14 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  4. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease

    Digestive and Liver Disease, 2012

    DOI 10.1016/j.dld.2012.08.017 PMID 22995553 23 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  5. Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease

    Scandinavian Journal of Gastroenterology, 2012

    DOI 10.3109/00365521.2012.725093 PMID 23137022 18 citations (Europe PMC) Source : OpenAlex

  6. Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans

    Gastroenterology Research and Practice, 2012

    DOI 10.1155/2012/159438 PMID 22611378 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  7. The effect of HLA-DQB1 alleles on virologic breakthroughs during chronic hepatitis B treatment with genetically low barrier drugs

    Clinics and Research in Hepatology and Gastroenterology, 2012

    DOI 10.1016/j.clinre.2012.10.013 PMID 23273495 5 citations (Europe PMC) Source : OpenAlex

  8. Sa1242 Serum Anti-MüLlerian Hormone Levels are Lower in Reproductive-Age Women With Crohn's Disease Compared to Healthy Control Women

    Gastroenterology, 2012

    DOI 10.1016/s0016-5085(12)60949-4 Source : OpenAlex

  9. SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease

    Medical Science Monitor, 2011

    DOI 10.12659/msm.881749 PMID 21525818 120 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  10. Serum Levels of Hepcidin in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease

    Metabolic Syndrome and Related Disorders, 2011

    DOI 10.1089/met.2010.0121 PMID 21417913 44 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  11. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease

    European Journal of Gastroenterology & Hepatology, 2011

    DOI 10.1097/meg.0b013e32834e8041 PMID 22157234 35 citations (Europe PMC) Source : OpenAlex

  12. Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome

    European Journal of Clinical Investigation, 2011

    DOI 10.1111/j.1365-2362.2011.02597.x PMID 21913918 28 citations (Europe PMC) Source : OpenAlex

  13. Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis

    Clinica Chimica Acta, 2011

    DOI 10.1016/j.cca.2011.08.025 PMID 21888902 17 citations (Europe PMC) Source : OpenAlex

  14. Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease

    Metabolic Syndrome and Related Disorders, 2011

    DOI 10.1089/met.2011.0111 PMID 22112193 20 citations (Europe PMC) Source : OpenAlex

  15. Characterization of Nonalcoholic Fatty Liver Disease Unrelated to the Metabolic Syndrome

    Gastroenterology, 2011

    DOI 10.1016/s0016-5085(11)64095-x Source : OpenAlex

  16. Plasma Fibrinogen-Like Protein 2 Levels in Patients with Non-Alcoholic Fatty Liver Disease

    Hepatogastroenterology, 2011

    DOI 10.5754/hge11248 PMID 22024080 15 citations (Europe PMC) Source : OpenAlex

  17. Ecstasy induced fatal hepatic failure.

    PubMed, 2011

    PMID 21725523 2 citations (Europe PMC) Source : OpenAlex

  18. Is the Lymphoma Risk Reduced in Viral Hepatitis? A Cirrhotic Patient With Triple Malignancies

    The American Journal of Gastroenterology, 2011

    DOI 10.1038/ajg.2011.214 PMID 21897412 Source : OpenAlex

  19. Metastatic Gastric Melanoma: A Challenging Diagnosis

    Tumori Journal, 2010

    DOI 10.1177/030089161009600321 PMID 20845816 12 citations (Europe PMC) Source : OpenAlex

  20. Mitochondrial neurogastrointestinal encephalomyopathy: Case report

    The Turkish Journal of Gastroenterology, 2010

    DOI 10.4318/tjg.2010.0106 PMID 20931438 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  21. NONALKOLİK KARACİĞER YAĞLANMASI VE STEATOHEPATİT

    DergiPark (Istanbul University), 2010

    DOI 10.18017/itfd.10884 Source : OpenAlex

  22. Melanoma metastasis to the breast: A diagnostic pitfall

    Cancer Detection and Prevention, 2009

    DOI 10.1016/j.canep.2009.04.001 PMID 19588546 5 citations (Europe PMC) Source : OpenAlex

  23. Üst gastrointestinal endoskopide tanı konan Ascaris lumbricoides olgusu

    DergiPark (Istanbul University), 2009

    DOI 10.17941/agd.76215 Texte intégral en libre accèsSource : OpenAlex

  24. mpaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease.

    Source : page de profil sur acibadem.com.tr